Patients can pick from a growing array of treatments, from same-day- results surgery to game-changing immunotherapy, to fight the most common type of cancer.
Immunotherapy Special Issue 2020
Across cancer types, a unique immune-stimulating treatment called tumor-infiltrating lymphocyte therapy produces durable remissions that could last for decades.
New immunotherapy combinations aim to turbocharge the immune system’s attack against cancer.
Advertisement
Advertisement
Trending on CURE
1
Tagrisso Plus Chemo Offers Survival benefit in EGFR+ NSCLC
2
Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer
3
Lenvima Combo Fails to Extend Survival in Esophageal Cancer
4
Imfinzi Not Associated With Bladder Cancer Quality of Life Decline
5
